New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
09:01 EDTPCYCPharmacyclics downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Pharmacyclics to Sector Perform and reduced its price target to $95 from $110 to reflect upcoming headwinds from ABBVIE and Gilead upcoming filings, slowing new scripts data, Phase III RESONATE data at ASCO might not have the buzz expected and lack of near-term catalysts.
News For PCYC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for PCYC

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use